share_log

HC Wainwright & Co. Reiterates Neutral on Kezar Life Sciencesto Neutral

Benzinga ·  19:20

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Kezar Life Sciences (NASDAQ:KZR) from Neutral to Neutral.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment